Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Mémantine (Ebixa®) : une nouvelle stratégie thérapeutique dans le traitement des formes modérément sévères à sévères de la maladie d’Alzheimer. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
The glutamatergic system and neurodegeneration in dementia : preventive strategies in Alzheimer's disease
10.1002/(sici)1099-1166(199901)14:1<3::aid-gps897>3.0.co;2-7 · 1999 · External reference
The Neuropsychiatric Inventory : comprehensive assessment of psychopathology in dementia
10.1212/wnl.44.12.2308 · 1994 · External reference
Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease – a unified glutamatergic hypothesis on the mechanism of action
10.1007/bf03033787 · 2000 · External reference
Alzheimer's disease : a public health problem : yes but a priority ?
2002 · External reference
Efficacy and tolerability of memantine in patients with dementia syndrome-A double-blind, placebo-controlled trial
1991 · External reference
Unresolved reference
External reference
Système cholinergique et traitement de la maladie d’Alzheimer
2001 · External reference
Unresolved reference
External reference
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
10.1212/wnl.57.4.613 · 2001 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
« Mini Mental State » : a practical method for grading the cognitive state of patients for the clinician
10.1016/0022-3956(75)90026-6 · 1975 · External reference
Epidemiology of dementia
2001 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Memantine in the treatment of mild to moderate dementia syndrome-a double-blind placebo-controlled study
1992 · External reference
Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy
10.1097/00004850-200303000-00003 · 2003 · External reference
A new clinical scale for the staging of dementia
10.1192/bjp.140.6.566 · 1982 · External reference
Unresolved reference
External reference
Potential and current use of N-Methyl-D-Aspartate (NMDA) receptor antagonists in diseases of aging
10.2165/00002512-200118100-00001 · 2001 · External reference
Unresolved reference
1990 · External reference
Prévalence de la démence en Gironde (France)
1993 · External reference
Théorie de l’excitotoxicité. Implication potentielle des acides aminés excitateurs dans les processus dégénératifs
2001 · External reference
Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate
10.1126/science.164.3880.719 · 1969 · External reference
Efficacy and safety of memantine in patients with mild to moderate vascular dementia : a randomized, placebo-controlled trial (MMM 300)
10.1161/01.str.0000020094.08790.49 · 2002 · External reference
Batterie d’évaluation neuropsychologique pour la démence grave
1992 · External reference
Unresolved reference
External reference
Glutamate in CNS disorders as a target for drug development : an update
10.1358/dnp.1998.11.9.863689 · 1998 · External reference
Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist – a review of preclinical data
10.1016/s0028-3908(99)00019-2 · 1999 · External reference
Unresolved reference
2002 · External reference
Prévalence de la démence et de la maladie d’Alzheimer chez les personnes âgées de 75 ans et plus : données réactualisées de la cohorte PAQUID
2003 · External reference
Functional staging of dementia of the Alzheimer's type
10.1111/j.1749-6632.1984.tb13859.x · 1984 · External reference
The Global Deterioration Scale for assessment of primary degenerative dementia
10.1176/ajp.139.9.1136 · 1982 · External reference
Memantine in moderate-to-severe Alzheimer's disease
10.1056/nejmoa013128 · 2003 · External reference
Unresolved reference
2000 · External reference
Functional Assessment Staging (FAST)
1988 · External reference
A prospective PMS study to validate the sensitivity for change of the D-Scale in advanced Stages of dementia using the NMDA-antagonist Memantine
10.1055/s-2000-341 · 2000 · External reference
Assessment of the severely impaired patient : description and validation of a new neuropsychological test battery
10.1037/1040-3590.2.3.298 · 1990 · External reference
Measuring cognition in advanced Alzheimer's disease for clinical trials
10.1007/978-3-7091-6139-5_14 · 2002 · External reference
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial
10.1001/jama.291.3.317 · 2004 · External reference
Severe dementia and its evaluation: scales for cognition, behavior and overall functioning
2001 · External reference
Unresolved reference
2002 · External reference
Glutamate receptors as a target for Alzheimer's disease – are clinical results supporting the hope ?
10.1007/978-3-7091-6139-5_20 · 2002 · External reference
Memantine in severe dementia : results of the 9M-best study (benefit and efficacy in severely demented patients during treatment with memantine)
10.1002/(sici)1099-1166(199902)14:2<135::aid-gps906>3.0.co;2-0 · 1999 · External reference
